(0.21%) 5 142.50 points
(0.16%) 38 504 points
(0.31%) 17 901 points
(-0.32%) $83.58
(1.82%) $1.958
(0.18%) $2 351.50
(0.56%) $27.69
(0.89%) $930.30
(-0.06%) $0.934
(-0.20%) $11.00
(-0.18%) $0.799
(1.20%) $92.98
0.00% HKD 0.960
Live Chart Being Loaded With Signals
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in developing and commercializing a pipeline of small molecule and biological therapeutics for androgen-receptor-related disease areas with unmet medical needs in the People's Republic of China and internationally...
Stats | |
---|---|
Volumen de hoy | 1.26M |
Volumen promedio | 11.66M |
Capitalización de mercado | 417.88M |
EPS | HKD0 ( 2024-03-28 ) |
Last Dividend | HKD0 ( N/A ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -0.360 |
ATR14 | HKD0.00500 (0.52%) |
Volumen Correlación
Kintor Pharmaceutical Ltd Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Kintor Pharmaceutical Ltd Correlación - Moneda/Commodity
Kintor Pharmaceutical Ltd Finanzas
Annual | 2022 |
Ingresos: | HKD0 |
Beneficio Bruto: | HKD0 (0.00 %) |
EPS: | HKD-2.53 |
FY | 2022 |
Ingresos: | HKD0 |
Beneficio Bruto: | HKD0 (0.00 %) |
EPS: | HKD-2.53 |
FY | 2021 |
Ingresos: | HKD34.23M |
Beneficio Bruto: | HKD34.23M (100.00 %) |
EPS: | HKD-2.72 |
FY | 2020 |
Ingresos: | HKD0.00 |
Beneficio Bruto: | HKD0.00 (0.00 %) |
EPS: | HKD-1.640 |
Financial Reports:
No articles found.
Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in developing and commercializing a pipeline of small molecule and biological therapeutics for androgen-receptor-related disease areas with unmet medical needs in the People's Republic of China and internationally. The company's products pipeline include Proxalutamide, a second generation androgen receptor (AR) antagonist for the treatment of metastatic castration-resistant prostate cancer, AR positive breast cancer, and COVID-19; and Pyrilutamide, an AR antagonist for the androgenetic alopecia (AGA) and acne vulgaris treatment. Its products pipeline also comprise ALK-1 antibody for the treatment of metastatic hepatocellular carcinoma (HCC) and various solid tumours; GT20029, a topical AR-PROTAC compound for the treatment of AGA and acne vulgaris; and PD-L1/TGF-ß, a dual target antibody to treat non-small cell lung cancer, biliary tract cancer, triple negative breast cancer, and HPV-associated tumours. In addition, the company's products pipeline include Detorsertib for the treatment of metastatic solid tumours, such as breast cancer, prostate cancer, and HCC; and Hedgehog/SMO Inhibitor, an inhibitor of the hedgehog signal transduction pathway to treat blood cancer and basal-cell carcinoma. Kintor Pharmaceutical Limited was founded in 2009 and is headquartered in Suzhou, the People's Republic of China.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico